Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol-S Injection vs mannitol injection for intracranial hypertension
CTR20254523Phase 3Active
- Sponsor
- Hunan Xianshi Pharmaceutical
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sorbitol + mannitol in intracranial hypertension (IH), sponsored by Hunan Xianshi Pharmaceutical. Started Nov 2025; status: active.
02
Drugs
sorbitol + mannitol
03
Conditions
intracranial hypertension (IH)
Beyond the preview
Go deeper on CTR20254523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254523.